Presenters at the 2023 San Antonio Breast Cancer Symposium (SABCS; December 5–9) reported the latest findings in breast cancer research. NEJM Group was on hand to cover the meeting. Here, NEJM Journal Watch Oncology and Hematology reports on some of the key studies, with clinical perspective provided by Editor-in-Chief Dr. William J. Gradishar and guest author Dr. Jasmine Sukumar. Dr. Sukumar is Assistant Professor in the Division of Cancer Medicine, Department of Breast Medical Oncology, at the University of Texas MD Anderson Cancer Center, Houston.
Abstracts are available on the SABCS site; registration is required to access the abstracts.
Drs. Gradishar and Sukumar discussed meeting highlights and their impact on patient care in an intervi…
Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)